American Shared Hospital Services (AMS) reports Q1 2026 revenue of $7.1M, up 15.9% YoY, with improved cash flow and strategic expansions planned.

Key Takeaways

• Revenue for Q1 2026 reached $7.1 million, a 15.9% increase year-over-year from $6.1 million.
• Adjusted EBITDA grew 18.4% to $1.1 million, compared to $949,000 in the same period last year.
• Net loss improved to $0.9 million or $0.09 per diluted share, from a net loss of $1.3 million or $0.10 per diluted share in Q1 2025.
• The company is on track to open a new radiation therapy center in Bristol, Rhode Island, and a proton beam therapy facility in Johnston, Rhode Island, in the coming years.
• Cash and cash equivalents increased to $5.2 million from $3.7 million at the end of 2025.

Financial Performance

American Shared Hospital Services reported a strong financial performance in the first quarter of 2026, with total revenue increasing by 15.9% year-over-year. The revenue growth was driven primarily by the company's Direct Patient Care Services segment, which generated approximately $4.1 million, up 30.2% from $3.1 million in Q1 2025.

Leasing revenue remained stable at approximately $3 million, showing consistency against the backdrop of a previously expired gamma knife customer contract. This revenue stability in the leasing segment, coupled with robust growth in direct patient services, underscores the company’s adaptability in maintaining diverse income streams.

The company's gross margin improved to 18.2%, or $1.3 million, reflecting higher revenue and better utilization across treatment centers. However, total costs of revenue rose to $5.8 million, primarily due to increased operating costs associated with the Direct Patient Services segment, including staffing and facility-related expenses. Despite these rising costs, the net loss attributable to the company showed improvement, indicating effective cost management and operational improvements.

Strategic Initiatives

A significant development in the quarter was the leadership transition, with Craig Tagawa appointed as interim CEO following Gary Delanis' departure. Tagawa brings over 35 years of experience with the company, positioning him well to continue the strategic initiatives aimed at scaling operations and enhancing service delivery.

The company is focusing on increasing treatment volumes across its facilities, particularly in Rhode Island and Puebla, Mexico, where recent enhancements in operational execution have yielded positive results. The collaboration with local health systems in Rhode Island is enhancing staffing and referral patterns, leading to improved operational execution and higher treatment volumes.

Moreover, the company is advancing its international strategy, with the Puebla center continuing to show strong growth. Future plans include the opening of a new radiation therapy center in Bristol, Rhode Island, in 18 to 24 months, and a proton beam therapy center in Johnston, which is projected to take 24 to 30 months to operationalize. These expansions are expected to drive long-term growth and strengthen partnerships with leading health systems in the region.

Future Outlook

Management expressed optimism about the company's trajectory, particularly in light of the expected revenue growth from new facilities and improvements in operational efficiencies. The current demand trends across both Linac and Proton therapy platforms are encouraging, with the expectation of capturing this demand as the company continues to enhance its clinical capabilities.

In terms of financial guidance, the management acknowledges that while the company is still reporting a net loss, the improvements in cash flow and operational performance signal that the business is beginning to realize the benefits of its strategic investments. Future performance is anticipated to improve as utilization rates continue to increase across treatment centers, contributing to enhanced revenue and margin expansion.

Craig Tagawa highlighted the importance of maintaining a strong focus on operational discipline, emphasizing that the company is committed to delivering long-term value for its shareholders. The increased cash balance to $5.2 million also reflects improved operating performance, which is crucial as the company pursues growth initiatives and manages its capital structure effectively.

Closing Assessment

Overall, American Shared Hospital Services demonstrated a robust performance in Q1 2026, characterized by significant revenue growth and operational improvements despite ongoing challenges. The leadership transition appears to be well-timed, with a seasoned executive at the helm guiding the company through its next growth phase. With strategic planning and a focus on enhancing patient care services, the company is positioned to capitalize on both domestic and international opportunities in the healthcare sector.

This analysis is based on public earnings call materials and is not investment advice.